Articles by Nancy Dreyer - Pharmaceutical Executive


Articles by Nancy Dreyer

Nancy Dreyer

Chief of Scientific Affairs and SVP, Outcome Sciences

Comparative Effectiveness Research: Coming Soon?
March 24, 2009

Only time will reveal CER's true definition, and determine the full effects of a CER-based system

Personalized Medicine Meets the Real World
June 1, 2006

Personalized medicines often come to market without much safety information. Small populations mean less data. Genzyme, for example, received FDA approval for Cerezyme, to treat Gaucher disease, based on a pivotal trial with only 30 patients.


Click here